Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.

David W DodickPeter J GoadsbyChristian LucasRigmor JensenJennifer N BardosJames M MartinezChunmei ZhouSheena K AuroraJyun Yan YangRobert R ConleyTina Oakes

Published in: Cephalalgia : an international journal of headache (2020)

NCT02438826; https://www.clinicaltrials.gov/ct2/show/NCT02438826.

Keyphrases

double blind
placebo controlled
clinical trial
phase iii
phase ii
computed tomography
open label
image quality
magnetic resonance imaging
dual energy
magnetic resonance
contrast enhanced
pet ct